We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.21B
AUM Growth
-$2.23B
Cap. Flow
-$2.52B
Cap. Flow %
-114.03%
Top 10 Hldgs %
15.59%
Holding
1,343
New
73
Increased
262
Reduced
819
Closed
93

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$5.69M
2
EQIX icon
Equinix
EQIX
+$4.68M
3
TFC icon
Truist Financial
TFC
+$3.89M
4
OUT icon
Outfront Media
OUT
+$3.62M
5
UNIT
Uniti Group
UNIT
+$3.02M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$190M
2
AAPL icon
Apple
AAPL
+$189M
3
AMZN icon
Amazon
AMZN
+$133M
4
META icon
Meta Platforms (Facebook)
META
+$50.3M
5
JPM icon
JPMorgan Chase
JPM
+$44M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Financials 15.18%
3 Real Estate 12.44%
4 Communication Services 9.06%
5 Consumer Staples 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
76
MetLife
MET
$61B
$4.7M 0.21%
92,144
+6,699
+8% +$323K
AFL icon
77
Aflac
AFL
$63.9B
$4.54M 0.21%
85,812
+6,164
+8% +$327K
VLO icon
78
Valero Energy
VLO
$89.8B
$4.49M 0.2%
47,919
-21,680
-31% -$2.05M
MPC icon
79
Marathon Petroleum
MPC
$90.3B
$4.48M 0.2%
74,304
-34,975
-32% -$2.19M
HCA icon
80
HCA Healthcare
HCA
$84.8B
$4.48M 0.2%
30,279
-1,029
-3% -$138K
MCO icon
81
Moody's
MCO
$81.7B
$4.44M 0.2%
18,692
+1,340
+8% +$298K
VRTX icon
82
Vertex Pharmaceuticals
VRTX
$121B
$4.43M 0.2%
20,256
-26,602
-57% -$5.38M
TDY icon
83
Teledyne Technologies
TDY
$30.4B
$4.32M 0.2%
12,459
-930
-7% -$313K
BTI icon
84
British American Tobacco
BTI
$132B
$4.29M 0.19%
101,143
-35,079
-26% -$1.32M
SNY icon
85
Sanofi
SNY
$104B
$4.23M 0.19%
84,201
+11,210
+15% +$525K
BIIB icon
86
Biogen
BIIB
$29.9B
$4.22M 0.19%
14,214
-40,427
-74% -$11.2M
OXY icon
87
Occidental Petroleum
OXY
$57B
$4.21M 0.19%
102,051
-62,306
-38% -$2.5M
ALL icon
88
Allstate
ALL
$66.9B
$4.17M 0.19%
37,071
+1,052
+3% +$115K
GSK icon
89
GSK
GSK
$103B
$4.15M 0.19%
70,710
-23,085
-25% -$1.28M
WBA
90
DELISTED
Walgreens Boots Alliance
WBA
$4.15M 0.19%
70,311
-173,542
-71% -$10M
T icon
91
AT&T
T
$165B
$4.1M 0.19%
138,931
-1,064,128
-88% -$30.7M
PM icon
92
Philip Morris
PM
$301B
$4.1M 0.19%
48,151
-180,232
-79% -$14.9M
DPZ icon
93
Domino's
DPZ
$11B
$4.08M 0.18%
13,895
-1,281
-8% -$353K
ABBV icon
94
AbbVie
ABBV
$458B
$4.08M 0.18%
46,083
-239,765
-84% -$19.9M
BP icon
95
BP
BP
$113B
$4.08M 0.18%
108,010
-9,852
-8% -$374K
VZ icon
96
Verizon
VZ
$194B
$4.02M 0.18%
65,506
-451,644
-87% -$27.2M
CVX icon
97
Chevron
CVX
$388B
$3.99M 0.18%
33,086
-210,241
-86% -$24.8M
MO icon
98
Altria Group
MO
$122B
$3.97M 0.18%
79,515
-212,055
-73% -$10M
TYL icon
99
Tyler Technologies
TYL
$12.2B
$3.95M 0.18%
13,157
-992
-7% -$276K
Y
100
DELISTED
Alleghany Corp
Y
$3.91M 0.18%
4,890
-459
-9% -$359K

Similar funds

Pacer Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Pacer Advisors held 1,343 positions worth $2.21B, down 50% from $4.45B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Pacer Advisors withdrew a net $2.52B in Q4 2019, closing 93 positions and reducing 819 holdings. Its most notable exit was Celgene Corp, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 12% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Pacer Advisors opened a new position in Dayforce worth $2.32M.

  • Pacer Advisors's largest Q4 2019 buy was Dayforce: 34,239 shares worth $2.32M.
  • Pacer Advisors added most to Crown Castle in Q4 2019, an estimated $5.69M increase.
  • Pacer Advisors's biggest Q4 2019 reduction was Microsoft, cutting an estimated $190M.
  • Pacer Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $17.5M.
  • Pacer Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q4 2019.
  • Pacer Advisors opened 73 new positions and closed 93 in Q4 2019.
  • Pacer Advisors's portfolio value fell 50% quarter-over-quarter to $2.21B.

Based on Pacer Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.